In a divisive election season, Daniel Noboa pledged to bring law and order. His opponent immediately contested the results.

Ecuadorian voters have reelected President Daniel Noboa, a conservative young millionaire with a divisive no-holds-barred ...

Presidential hopefuls incumbent President Daniel Noboa and leftist lawyer Luisa González voted on Sunday in the country’s ...

Stand on the equator line at Mitad del Mundo and experience the unique feeling of being in two hemispheres at once! It’s an unforgettable Ecuador adventure. #Equator #MitadDelMundo # ...

‘The Last of Us' Season 2 Needs More Us, Less Them European Union ‘ready to negotiate’ with Trump on zero-for-zero tariffs Massive Number of US Bombers Performing Hypnotic Flyover Formation ...

Stopover, admire and buy yourself souvenirs. Proceed to the Equator line taken as one beautiful scenery in Africa the pathway of the sun and take photographs. Early afternoon, arrive in Lake Mburo for ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

They’d never even visited Ecuador before, but Brittany and Blake Bowen, from the United States, decided to move to the South American country in 2021 to give their four children a completely ...

There are no approved treatments for first-line aGVHD. The Phase 3 ... plus systemic corticosteroids (79 subjects) The EQUATOR study remains ongoing with all patients having completed dosing, and 30 ...

The Phase 3 EQUATOR study in first-line aGVHD demonstrated a favorable safety and tolerability profile, and clinically meaningful longer-term outcomes. There was no meaningful difference in CR or ORR, ...

The Phase 3 EQUATOR study in first-line aGVHD demonstrated a favorable safety and tolerability profile, and clinically meaningful longer-term outcomes. There was no meaningful difference in CR or ...

There are no approved treatments for first-line aGVHD. The Phase 3 ... plus systemic corticosteroids (79 subjects) The EQUATOR study remains ongoing with all patients having completed dosing ...